Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The investigators plan to see what factors can influence the durability of Exelon patch
treatment in Korean patients with Alzheimer's disease.
Based on these results, the investigators will find the ways to maximize the effect and
durability of Exelon patch on Korean patients with Alzheimer's disease.
After finishing this study, the investigators are going to present the study results at the
international and national academic meetings or conferences.
Also the investigators expect that they can publish the result in a journal of in the field
of neurology or dementia till the winter of 2010.
Details
Lead Sponsor:
Seoul National University Hospital
Collaborators:
Bobath Memorial Hospital Chung-Ang University Hosptial, Chung-Ang University College of Medicine Dong-A University Hospital Ewha Womans University Hallym University Medical Center Hanyang University Hanyang University Seoul Hospital Inha University Hospital Inje University Jeju National University Konyang University Hospital Korea University Kwandong University Myongji Hospital Kyunghee University Medical Center Pusan National University Hospital Seoul National University Bundang Hospital Seoul St. Mary's Hospital SungAe General Hospital Wonkwang University Sanbon Medical Center Yong-in Hyoja Geriatric Hospital